<DOC>
	<DOCNO>NCT01119352</DOCNO>
	<brief_summary>The aim study ass safety , tolerability , pharmacokinetics pharmacodynamics AZD7687 follow multiple ascend dose administration overweight obese otherwise healthy male subject</brief_summary>
	<brief_title>AZD7687 Multiple Ascending Dose Study</brief_title>
	<detailed_description />
	<mesh_term>Overweight</mesh_term>
	<criteria>Provision sign date , write informed consent prior study specific procedure suitable vein cannulation repeat venepuncture . Have body mass index ( BMI ) 27 35 kg/m2 Fasting serum ( S ) glucose ≥7.0 mmol/L nonfasting Sglucose ≥11.1 mmol/L screen . Any eating disorder actively attempt loose weight within 3 month prior enrolment . Smoking 7 cigarette per week time consent</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>Safety</keyword>
	<keyword>tolerability</keyword>
	<keyword>PK</keyword>
	<keyword>healthy</keyword>
	<keyword>overweight</keyword>
	<keyword>obese</keyword>
</DOC>